Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Siemens Healthineers AG News & Analysis
stocks
3 overvalued ASX stocks with cheaper alternatives
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,039.80 | 82.70 | -0.91% |
CAC 40 | 7,854.61 | 36.39 | 0.47% |
DAX 40 | 23,674.53 | 315.35 | 1.35% |
Dow JONES (US) | 46,142.42 | 124.10 | 0.27% |
FTSE 100 | 9,228.11 | 32.45 | 0.35% |
HKSE | 26,663.80 | 225.29 | 0.85% |
NASDAQ | 22,470.72 | 209.40 | 0.94% |
Nikkei 225 | 45,321.95 | 419.68 | 0.93% |
NZX 50 Index | 13,160.57 | 74.32 | -0.56% |
S&P 500 | 6,631.96 | 31.61 | 0.48% |
S&P/ASX 200 | 8,754.80 | 93.70 | -1.06% |
SSE Composite Index | 3,864.81 | 11.53 | -0.30% |